Westley Group Score

The Westley Croup Score is a validated clinical assessment tool that quantifies the severity of croup (laryngotracheobronchitis) in children, guiding treatment decisions and disposition planning. Croup is a viral infection causing inflammation of the larynx, trachea, and bronchi, resulting in characteristic barking cough, inspiratory stridor, and varying degrees of respiratory distress, most commonly affecting children ages 6 months to 3 years. The score evaluates five clinical parameters with weighted point values totaling a maximum of 17 points: (1) Level of consciousness (0-5 points)—Normal including sleep = 0, Disoriented = 5, reflecting hypoxemia or hypercarbia severity; (2) Cyanosis (0-5 points)—None = 0, With agitation = 4, At rest = 5, indicating severe hypoxemia; (3) Stridor (0-5 points)—None = 0, With agitation only = 1, At rest = 2, indicating degree of laryngeal narrowing; (4) Air entry (0-5 points)—Normal = 0, Decreased = 1, Markedly decreased = 2, reflecting airway obstruction severity; (5) Retractions (0-5 points)—None = 0, Mild = 1, Moderate = 2, Severe = 3, indicating work of breathing and respiratory muscle fatigue. Score interpretation stratifies severity: 0-2 points = mild croup (85-90% of cases)—minimal symptoms, no stridor at rest, suitable for outpatient management with supportive care; 3-5 points = moderate croup (5-10% of cases)—stridor at rest, mild-moderate distress, requires observation and medical treatment (dexamethasone, nebulized epinephrine); 6-11 points = severe croup (1-3% of cases)—significant respiratory distress, markedly decreased air entry, requires hospitalization with intensive monitoring; ≥12 points = impending respiratory failure (<1% of cases)—critical obstruction requiring immediate intervention, possible intubation, ICU admission. For example, a 2-year-old with barking cough, stridor only when crying (1 point), normal air entry (0 points), mild subcostal retractions (1 point), normal consciousness (0 points), and no cyanosis (0 points) scores 2 points total, indicating mild croup manageable at home with single dose of oral dexamethasone. The Westley Score demonstrates excellent inter-rater reliability (correlation 0.82-0.88) and correlates strongly with objective measures like tracheal narrowing on X-ray and oxygen saturation, validating its clinical utility for standardizing assessment and ensuring appropriate resource allocation.

Accurate scoring requires systematic evaluation of specific clinical signs, with assessment preferably performed while the child is calm in a parent's lap, as agitation artificially worsens stridor and retractions. Level of consciousness (0 or 5 points): Assess mental status—normal includes alert, playful, consolable, or sleeping peacefully (0 points). Disorientation, lethargy, agitation despite parental comfort, or inability to maintain attention indicates altered consciousness (5 points), suggesting severe hypoxemia (SpO2 typically <90%) or hypercarbia (CO2 retention from respiratory fatigue). This binary scoring (0 or 5) reflects that altered consciousness represents either normal or critically abnormal without intermediate states. Cyanosis (0, 4, or 5 points): Observe mucous membranes (lips, tongue, inside mouth) and nail beds for blue discoloration. None with normal pink color = 0 points. Cyanosis appearing only during crying, coughing, or agitation = 4 points, indicating borderline oxygenation (SpO2 typically 88-92%) with desaturation during increased oxygen demand. Cyanosis present at rest = 5 points, indicating severe hypoxemia (SpO2 typically <85%) requiring immediate oxygen therapy and medical intervention. Note that peripheral cyanosis (blue hands/feet from cold) differs from central cyanosis and should not be scored. Stridor (0, 1, or 2 points): Listen for the high-pitched, musical breathing sound characteristic of upper airway obstruction. None = 0 points—child breathes quietly even when crying. Heard only with agitation/crying = 1 point—indicates mild laryngeal narrowing (approximately 50-70% of normal diameter) that becomes audible only when increased airflow velocity exceeds the stenotic segment's capacity. Heard at rest = 2 points—indicates moderate-severe narrowing (approximately 30-50% of normal diameter) producing turbulent flow even during quiet breathing. Paradoxically, diminishing stridor with worsening retractions and air entry suggests critical narrowing where insufficient airflow occurs to generate sound, indicating impending complete obstruction. Air entry (0, 1, or 2 points): Auscultate chest bilaterally comparing breath sounds to normal. Normal bilateral breath sounds clearly heard throughout lung fields = 0 points. Decreased air entry = 1 point—breath sounds present but quieter than normal, requiring more careful listening, indicating moderate obstruction reducing tidal volume. Markedly decreased or barely audible = 2 points—breath sounds extremely faint despite respiratory effort, indicating severe obstruction with minimal effective ventilation. Assess carefully distinguishing decreased air entry (obstruction) from increased upper airway sounds transmitted to chest (not decreased entry). Retractions (0-3 points): Observe chest wall movement during inspiration, noting which anatomical sites demonstrate inward movement (paradoxical motion) as negative intrathoracic pressure overcomes chest wall structural integrity. None = 0 points—chest expands normally outward during inspiration. Mild = 1 point—subtle intercostal (between ribs) or subcostal (below rib cage) retractions visible only during deep breaths or crying. Moderate = 2 points—clear suprasternal (above sternum), supraclavicular (above collarbones), and intercostal retractions visible during quiet breathing. Severe = 3 points—marked retractions involving all sites (suprasternal, supraclavicular, intercostal, subcostal) with possible sternal retractions and nasal flaring, indicating extreme respiratory effort and impending muscle fatigue. Retractions severity correlates with degree of obstruction and work of breathing—mild retractions may be compensatory and sustainable for hours, while severe retractions indicate unsustainable work predicting respiratory failure within 30-60 minutes without intervention. Assessment tips: (1) Allow 5-10 minutes observation with child calm before scoring—agitation increases all parameters artificially. (2) Have parent hold child upright in position of comfort—supine positioning worsens symptoms. (3) Avoid unnecessary examination (throat inspection) that triggers crying and worsens stridor. (4) Assess room air oxygen saturation with pulse oximetry—SpO2 <92% suggests moderate-severe croup even if other signs seem mild. (5) Score based on worst observed during assessment period, not transient improvement. (6) Reassess score 30-60 minutes after treatment (dexamethasone and/or epinephrine) to document response and guide disposition. For example, a child initially scoring 6 points (moderate-severe) who improves to 3 points post-treatment may be suitable for observation and potential discharge, while persistent score ≥6 indicates hospitalization need.

Treatment decisions follow evidence-based protocols stratified by Westley Score severity, with specific interventions proven to reduce symptoms, hospitalization rates, and respiratory failure risk. Mild croup (0-2 points): Management focuses on supportive care and single-dose corticosteroid. (1) Oral dexamethasone 0.15-0.6 mg/kg (single dose, maximum 10 mg) reduces symptom duration by 24-36 hours, decreases return visits by 50%, and prevents progression to moderate-severe disease in 85-90% of cases. For example, a 15 kg (33 lb) child receives 2.25-9 mg dexamethasone (typically 3-4 mg oral suspension). Benefits appear within 2-4 hours, peak at 12-24 hours, and persist 48-72 hours. (2) Humidified air (cool mist) provides symptomatic relief though systematic reviews show modest objective benefit—mainly comforts child and parents. (3) Adequate hydration—encourage oral fluids to maintain adequate intake. (4) Minimal handling—avoid agitation that worsens symptoms. (5) Parental education—provide return precautions for worsening stridor at rest, increased work of breathing, inability to drink, or altered consciousness. Expected outcome: 95% improve with outpatient management, symptoms peak at 24-48 hours then gradually resolve over 3-5 days, with barking cough potentially persisting 7-10 days. Moderate croup (3-5 points): Requires medical facility observation with corticosteroids and consideration of nebulized epinephrine. (1) Dexamethasone 0.6 mg/kg oral/IM (single dose, max 10 mg)—higher dose than mild croup, with IM route if vomiting or severe distress prevents oral administration. (2) Nebulized racemic epinephrine (0.5 mL of 2.25% solution in 2.5 mL saline) or L-epinephrine (5 mL of 1:1000 solution) provides rapid but temporary improvement within 10-30 minutes through alpha-adrenergic vasoconstriction reducing mucosal edema. Peak effect at 60-90 minutes, duration 2-3 hours. For example, a child with Westley Score 4 (stridor at rest, mild retractions) receiving nebulized epinephrine typically improves to score 1-2 within 30 minutes, allowing comfortable breathing, but may rebound to score 3-4 after 2-3 hours as epinephrine effects wane. (3) Observation period 2-4 hours post-epinephrine to monitor for rebound—persistent score ≤2 without return of stridor indicates safe discharge, while rebound to score ≥3 or need for repeat epinephrine indicates admission. (4) Supplemental oxygen if SpO2 <92%. Expected outcome: 70-80% improve sufficiently for discharge after observation, 20-30% require admission for ongoing symptoms or repeated epinephrine needs. Severe croup (6-11 points): Requires hospitalization with intensive monitoring and aggressive treatment. (1) Dexamethasone 0.6 mg/kg IM (or IV if line placed). (2) Nebulized epinephrine repeated every 30-60 minutes as needed—maximum typically 3-4 doses before considering escalation. (3) Continuous pulse oximetry and cardiorespiratory monitoring. (4) Supplemental oxygen to maintain SpO2 >92%, delivered via blow-by or nasal cannula (avoid mask that agitates child). (5) Minimal stimulation—IV placement, labs, X-rays deferred unless absolutely necessary to avoid worsening obstruction. (6) Position of comfort—upright in parent's lap typically optimal. (7) Nothing by mouth (NPO) if impending respiratory failure possible—aspiration risk. (8) Anesthesia/ENT consultation if score remains ≥8 despite treatment or if deterioration occurs. Expected outcome: 90-95% respond to medical management and avoid intubation, with improvement over 24-48 hours allowing step-down from intensive monitoring. 5-10% require intubation, typically those with score ≥10 or rapid deterioration. Impending respiratory failure (≥12 points): Requires immediate ICU-level care with preparation for emergency airway management. (1) Immediate nebulized epinephrine while preparing for intubation. (2) 100% oxygen via non-rebreather or blow-by. (3) ICU admission with anesthesia and ENT at bedside. (4) Avoid sedation—may precipitate complete obstruction by reducing compensatory muscle tone. (5) Heliox (helium-oxygen mixture, typically 70:30) may provide temporary benefit by reducing turbulent flow and work of breathing due to helium's lower density, buying time for corticosteroid/epinephrine effects. (6) Preparation for intubation—difficult airway anticipated due to laryngeal edema, typically requiring 0.5-1.0 mm smaller endotracheal tube than age-predicted, performed by most experienced provider with backup plan for surgical airway. Expected outcome: 30-50% with score ≥12 require intubation, typically for 3-5 days until airway edema resolves. Mortality with appropriate management <0.1%, but delayed recognition and treatment of impending respiratory failure increases risk substantially. Treatment pitfalls to avoid: Using sedatives (cause respiratory depression and loss of compensatory mechanisms), performing throat examination (may precipitate complete obstruction), forcing supine position (worsens obstruction), delaying epinephrine in moderate-severe disease (allows progression), premature discharge after single epinephrine dose without observation period (rebound effect causes deterioration 2-3 hours post-discharge).

Croup is caused by viral infection of the subglottic airway, with parainfluenza virus (types 1, 2, 3) accounting for 75-80% of cases, followed by respiratory syncytial virus (RSV) 10-15%, influenza A and B 5-10%, adenovirus 3-5%, and occasionally coronavirus, rhinovirus, or enterovirus. The infection causes mucosal inflammation, edema, and increased secretions in the larynx, trachea, and bronchi, with the subglottic region (below vocal cords) particularly vulnerable because it's the narrowest part of pediatric airway and is encircled by non-distensible cricoid cartilage—even 1 mm of circumferential edema reduces cross-sectional area by 35-50% in young children. Peak incidence occurs in children ages 6 months to 3 years (60-70% of cases), with occasional cases in children up to age 6 years. Infants under 6 months develop croup less frequently due to protective maternal antibodies. Boys are affected 1.5:1 ratio compared to girls. Seasonal pattern shows peak incidence in late autumn and early winter (October-December in Northern Hemisphere) coinciding with parainfluenza circulation, though sporadic cases occur year-round. Risk factors for severe croup: (1) Age <12 months—smaller baseline airway diameter means less edema tolerance; (2) Pre-existing airway abnormality—subglottic stenosis, tracheomalacia, hemangioma; (3) History of severe croup episodes; (4) Underlying neurological conditions affecting airway protection; (5) Immunocompromised status—prolonged symptoms, bacterial superinfection risk. Typical presentation: Prodromal upper respiratory symptoms (rhinorrhea, low-grade fever 38-39°C / 100-102°F) for 12-48 hours, followed by abrupt onset of characteristic barking cough (described as "seal-like" or "barking dog"), inspiratory stridor, and hoarse voice. Symptoms typically worsen at night and with agitation. Fever rarely exceeds 39°C (102°F)—higher fever suggests bacterial tracheitis. Duration 3-7 days with peak severity at 24-48 hours. Differential diagnosis—distinguishing croup from other causes of stridor: Bacterial tracheitis (life-threatening, requires IV antibiotics): high fever (39.5-40°C / 103-104°F), toxic appearance, rapid progression over hours, purulent secretions, often preceded by viral croup that suddenly worsens, requires intubation in 70-80% of cases. Epiglottitis (medical emergency, now rare due to Haemophilus influenzae type B vaccine): abrupt onset without prodrome, high fever, drooling, tripod positioning (leaning forward with mouth open), muffled voice (not hoarse), refusal to lie down, appears toxic, stridor may be minimal initially. Absence of barking cough distinguishes from croup. Retropharyngeal abscess: neck stiffness, severe sore throat, difficulty swallowing, neck held in extension, lateral neck X-ray or CT shows retropharyngeal swelling >7 mm at C2 or >14 mm at C6. Foreign body aspiration: sudden onset without prodrome during eating or playing with small objects, unilateral wheeze more common than stridor, asymmetric chest findings, history of choking episode. Allergic angioedema: rapid onset (minutes-hours), history of allergen exposure or ACE inhibitor use, facial swelling, urticaria, absence of fever, responds to epinephrine/antihistamines/corticosteroids. Spasmodic croup (non-infectious variant): recurrent episodes without fever or viral prodrome, sudden nighttime onset of barking cough and stridor, resolves within hours (often before reaching medical care), may be allergy or gastroesophageal reflux-mediated. Peritonsillar abscess: unilateral findings, uvula deviation, trismus (limited jaw opening), drooling, muffled "hot potato" voice. Key distinguishing features of viral croup: gradual onset after URI prodrome, low-grade fever, barking cough (most characteristic), hoarse voice, inspiratory stridor, responds to corticosteroids and epinephrine, child appears relatively well between coughing episodes (unlike bacterial tracheitis). Diagnostic evaluation: Croup is primarily a clinical diagnosis not requiring routine imaging or laboratory testing. Anteroposterior neck X-ray may show "steeple sign" (subglottic narrowing) in 40-50% of cases but has poor sensitivity and specificity, and radiation exposure risk often outweighs diagnostic benefit. X-rays are reserved for atypical presentations raising concern for alternative diagnoses. Laryngoscopy is avoided in acute setting because instrumentation may precipitate complete obstruction; performed only in operating room with anesthesia present if alternative diagnosis suspected. Pulse oximetry provides objective assessment—SpO2 <92% indicates moderate-severe disease requiring hospitalization. Most children with croup are managed based on clinical assessment using Westley Score without additional testing, as the characteristic presentation (gradual onset, barking cough, inspiratory stridor, hoarse voice, low fever) combined with appropriate age and season makes diagnosis straightforward in typical cases.

Understanding treatment timelines and recognizing inadequate response enables appropriate escalation preventing deterioration and respiratory failure. Dexamethasone response timeline: Oral or intramuscular dexamethasone demonstrates initial effects within 2-4 hours, with patients reporting subjective improvement in breathing comfort and reduction in stridor frequency. Peak benefit occurs at 12-24 hours after administration, when anti-inflammatory effects maximally reduce subglottic edema—Westley Score typically decreases by 2-4 points from baseline. For example, a child with initial score of 4 (moderate croup) typically improves to score 1-2 by 12-24 hours post-dexamethasone. Duration of benefit extends 48-72 hours from single dose, covering the typical peak symptom period. Approximately 5-10% of patients experience symptom recurrence after 72 hours as medication effects wane while viral inflammation persists—these children may benefit from second dexamethasone dose though routine repeated dosing is not recommended. Failure to improve after 4-6 hours (persistent score ≥4-5 or worsening score) suggests either severe disease requiring additional treatment or alternative diagnosis (bacterial tracheitis, foreign body, abscess) requiring reevaluation. Nebulized epinephrine response timeline: Effects appear remarkably rapidly—improvement begins within 10-15 minutes, with decreased work of breathing, quieter stridor, and improved air entry noticeable during nebulizer treatment. Peak effect at 60-90 minutes post-treatment shows maximum symptom reduction, with Westley Score commonly decreasing by 3-5 points. For example, a child with score 7 (severe croup) may improve to score 2-3 within an hour of epinephrine administration, appearing comfortable and playful. However, rebound effect occurs at 2-3 hours as vasoconstrictor effects dissipate, causing return of symptoms—score may return to within 1-2 points of pre-treatment value. This rebound phenomenon necessitates minimum 2-4 hour observation period after last epinephrine dose before discharge consideration. Discharge criteria after epinephrine treatment: (1) Score ≤2 sustained for 2+ hours after epinephrine effects have worn off (typically 3-4 hours post-treatment); (2) No stridor at rest; (3) Able to tolerate oral fluids; (4) SpO2 >94% on room air; (5) Reliable parents with transportation and ability to return if symptoms worsen. Discharging during the "peak effect window" (30-90 minutes post-epinephrine) when child appears dramatically improved is dangerous—rebound at home 2-3 hours later may result in emergency return with severe distress. Indications for repeat epinephrine: Rebound symptoms returning to score ≥4, increasing work of breathing, stridor at rest reappearing, or SpO2 declining below 92%. Repeat dosing typically follows same timeline—improvement within 10-15 minutes, peak at 60-90 minutes, duration 2-3 hours. Need for second epinephrine dose within 2 hours indicates severe disease requiring hospitalization regardless of response, as frequent dosing requirements suggest inadequate response to corticosteroids and high risk of respiratory failure. Need for three or more epinephrine doses or doses at <90-minute intervals suggests either bacterial tracheitis (requiring antibiotics), critical obstruction approaching intubation threshold, or rarely alternative diagnosis. Hospitalization indications: (1) Persistent score ≥4 after treatment; (2) Required >1 epinephrine dose in emergency department; (3) SpO2 <92% on room air despite treatment; (4) Moderate-severe retractions persisting 2+ hours post-treatment; (5) Altered consciousness; (6) Cyanosis; (7) Age <6 months; (8) Pre-existing airway abnormality; (9) Social factors—unreliable follow-up, distance from medical care >30 minutes, parental anxiety impairing home care capability. ICU admission criteria: (1) Score ≥8 despite maximal treatment; (2) Required ≥3 epinephrine doses; (3) Progressive deterioration despite treatment; (4) Altered consciousness from hypoxemia or hypercarbia; (5) SpO2 <88% on supplemental oxygen; (6) Signs of impending respiratory failure—severe retractions, paradoxical breathing (chest and abdomen moving opposite directions), head bobbing, decreased air entry, deteriorating mental status. Intubation indicators: (1) Score ≥12; (2) Exhaustion—decreasing respiratory effort despite worsening obstruction (ominous sign); (3) Progressive hypoxemia (SpO2 <85%) despite 100% oxygen; (4) Hypercarbia (PCO2 >60 mmHg) indicating respiratory failure; (5) Altered consciousness progressing to obtundation; (6) Apneic episodes; (7) Cardiovascular instability—bradycardia, hypotension indicating severe hypoxemia. Treatment failure patterns: Rapid deterioration (worsening within 1-2 hours despite treatment) suggests bacterial tracheitis, foreign body, or severe viral croup—requires immediate ICU consultation and preparation for intubation. Plateau response (initial improvement then stagnation at score 4-6 for >6 hours) indicates severe disease requiring admission and consideration of adjunctive therapies (heliox, high-humidity oxygen, possibly dexamethasone repeat dosing). Episodic deterioration (improvement then sudden worsening) may indicate mucus plugging—gentle suctioning or encouraging effective cough may help, but also consider pneumothorax (rare complication) or bacterial superinfection. Recognition of these patterns allows timely escalation: mild croup managed outpatient, moderate croup requiring emergency department observation and single epinephrine dose typically discharged if improved, severe croup requiring admission, and impending respiratory failure requiring ICU with intubation capability immediately available. The majority of children (85-90%) have mild disease responding to single dexamethasone dose without requiring epinephrine or hospitalization, while 8-10% need emergency department treatment with epinephrine, 2-5% require hospitalization, and <1% require intubation when appropriate early treatment is provided.

Most children with croup experience complete resolution without long-term sequelae, though recurrence patterns and persistent symptoms warrant evaluation for underlying structural abnormalities. Typical acute episode course: Symptoms peak at 24-48 hours after onset, gradually improve over 3-5 days, with complete resolution by 7-10 days. Barking cough may persist longest, occasionally continuing 10-14 days even as stridor and respiratory distress have resolved. Viral shedding continues 7-10 days, making patients infectious during this period. Short-term complications in typical viral croup are uncommon (<1-2%): Pneumonia from bacterial superinfection (most commonly Staphylococcus aureus, Streptococcus pneumoniae) occurs in <1% of hospitalized croup patients, presenting with high fever, focal chest findings, and radiographic infiltrate. Pulmonary edema from high negative inspiratory pressure (attempting to breathe through obstructed airway) causes transient hypoxemia and diffuse crackles, typically resolving within 24-48 hours with supportive care. Pneumothorax or pneumomediastinum from excessive inspiratory effort rarely occurs (<0.1% of severe cases), presenting with sudden deterioration, subcutaneous emphysema, or unilateral decreased breath sounds. Long-term pulmonary outcomes: No evidence of chronic lung disease, reactive airway disease, or pulmonary function abnormalities in children with typical croup history. Longitudinal studies following children with croup episodes show normal spirometry and no increased asthma incidence compared to controls, indicating viral croup does not cause permanent airway damage. Recurrent croup patterns: Single recurrence (second episode) occurs in 15-20% of children, typically within 6-12 months of initial episode, usually coinciding with subsequent viral upper respiratory infection. This is considered normal and does not indicate underlying pathology. Multiple recurrences (3+ episodes) affect 5-8% of children—termed "recurrent croup" or "croup-prone child." Evaluation for underlying airway abnormality is warranted after 3+ episodes, particularly if occurring outside typical age range (>3 years), requiring intubation, or showing progressively more severe manifestations. Spasmodic croup describes recurrent episodes without fever or viral prodrome, sudden nighttime onset, resolution within 2-6 hours (often before medical evaluation), thought related to allergy or gastroesophageal reflux rather than infection. These children may benefit from gastroesophageal reflux treatment or environmental allergen control rather than antiviral strategies. Underlying airway abnormalities to consider in recurrent/severe croup: Subglottic stenosis—congenital or acquired (from prior intubation) narrowing of subglottic region reduces baseline airway diameter, making even mild viral edema symptomatic. Presents with recurrent croup episodes, stridor with minor illnesses, exercise-induced stridor. Diagnosed by flexible laryngoscopy showing narrowed subglottic area, potentially requiring surgical treatment (balloon dilation, cricoid split, laryngotracheal reconstruction) if severe. Subglottic hemangioma—vascular lesion in subglottic space causing progressive stridor in first 6-12 months of life, worsening with crying, may have associated cutaneous hemangiomas (50% of cases). Peak growth at 3-6 months with spontaneous involution beginning around 12 months. Diagnosed by laryngoscopy showing bluish subglottic mass, treated with beta-blockers (propranolol, oral or intralesional), laser therapy, or surgical excision if severe. Tracheomalacia/laryngomalacia—softening of airway cartilage causing dynamic collapse during breathing, presents with chronic stridor (worse with agitation, feeding, upper respiratory infections), barking cough, recurrent croup-like symptoms. Diagnosed by flexible bronchoscopy showing airway collapse during breathing, usually improves spontaneously by age 18-24 months as cartilage matures. Severe cases may require supraglottoplasty or tracheostomy. Laryngeal papillomatosis—recurrent respiratory papillomatosis (RRP) caused by human papillomavirus (HPV) types 6 and 11, presenting with progressive hoarseness, stridor, breathing difficulty, recurrent croup-like symptoms not responding typically to treatment. Diagnosed by direct laryngoscopy showing multiple papillomas on vocal cords and larynx, requiring repeated surgical debulking procedures. Vascular ring/sling—congenital vascular anomaly (double aortic arch, aberrant subclavian artery) compressing trachea, causing chronic stridor, cough, recurrent respiratory infections, difficulty swallowing. Diagnosed by CT angiography or MRA showing vascular compression, treated surgically. Gastroesophageal reflux disease (GERD)—chronic reflux irritates larynx causing edema and inflammation, predisposing to severe symptoms with viral infections. Consider in children with chronic cough, hoarseness, feeding difficulties, recurrent pneumonia along with recurrent croup. Treatment with acid suppression (proton pump inhibitors) may reduce croup frequency. Indications for subspecialty referral: (1) Otolaryngology (ENT) referral: ≥3 croup episodes, croup occurring outside typical age range (>6 years or <3 months), required intubation, chronic stridor between croup episodes, progressive symptoms, history of airway surgery or prolonged intubation, associated dysphagia or aspiration. ENT evaluation includes flexible laryngoscopy (office-based visualization of larynx and vocal cords) and potentially direct laryngoscopy and bronchoscopy (operating room examination under anesthesia for detailed evaluation and potential intervention). (2) Pulmonology referral: recurrent lower respiratory tract infections, chronic cough, exercise-induced symptoms, concern for tracheomalacia or bronchial abnormalities, need for pulmonary function testing. (3) Gastroenterology referral: suspected GERD contributing to recurrent croup, chronic regurgitation, failure to thrive, feeding difficulties. Prevention strategies: Annual influenza vaccination reduces influenza-associated croup (5-10% of cases). Hand hygiene and respiratory etiquette reduce viral transmission but cannot prevent croup entirely given multiple causative viruses. No specific croup vaccine exists (though parainfluenza vaccines are in development). Genetic factors may predispose certain children to recurrent croup, though specific genetic markers have not been identified. Environmental tobacco smoke avoidance reduces respiratory infection severity. Breastfeeding provides some immune protection reducing croup incidence and severity in infants. For families managing recurrent croup, providing home action plans with dexamethasone prescription for early administration at symptom onset, clear return precautions, and low threshold for medical evaluation helps optimize outcomes and reduce anxiety. Most children outgrow croup susceptibility by age 6-7 years as airway diameter increases and immune system matures, allowing even recurrent croup children to expect resolution with age.

The Westley Croup Score serves as an objective standardization tool supplementing clinical judgment rather than replacing comprehensive assessment, with specific applications and recognized limitations requiring contextual interpretation. Appropriate clinical applications: (1) Severity stratification at initial assessment—Systematic scoring ensures evaluation of all relevant parameters (consciousness, cyanosis, stridor, air entry, retractions) preventing oversight of subtle signs. For example, a child with prominent barking cough but minimal visible distress might seem reassuring until systematic scoring reveals stridor at rest (2 points), decreased air entry (1 point), and mild retractions (1 point) totaling score 4, indicating moderate disease requiring observation and treatment rather than immediate discharge. (2) Treatment decision algorithms—Many institutions use score-based protocols: 0-2 points = dexamethasone 0.15-0.6 mg/kg oral with discharge instructions; 3-5 points = dexamethasone 0.6 mg/kg plus nebulized epinephrine with 2-4 hour observation; 6-11 points = admission with repeated epinephrine and intensive monitoring; ≥12 points = ICU admission with intubation preparation. These standardized approaches reduce practice variation and ensure appropriate resource allocation. (3) Documentation of treatment response—Serial scoring (pre-treatment, 30 minutes post-treatment, 2 hours post-treatment, 4 hours post-treatment) objectively quantifies improvement or deterioration, guiding disposition decisions. For example, improvement from score 6 to 2 after epinephrine and dexamethasone suggests adequate response potentially allowing discharge after observation, while persistent score ≥5 or worsening score indicates admission need. (4) Research standardization—Clinical trials evaluating croup treatments use Westley Score as primary outcome measure, enabling comparison across studies and validation of interventions. Studies demonstrating dexamethasone reduces Westley Score by average 2-3 points at 6 hours and epinephrine by 3-4 points at 30 minutes established these therapies as evidence-based standards. (5) Quality improvement monitoring—Emergency departments and hospitals track Westley Scores in croup patients to evaluate treatment protocol compliance, identify undertreated patients (high scores not receiving epinephrine), and monitor inappropriate admission/discharge patterns. (6) Education and training—Teaching systematic scoring to residents, medical students, and nurses enhances recognition of severity indicators and standardizes assessment approach across providers. (7) Communication tool—Conveying "Westley Score 7" to accepting hospitalist or intensivist provides immediate objective severity understanding beyond subjective descriptors like "moderately severe stridor." Important limitations requiring awareness: (1) Age-dependent applicability—Score was validated primarily in children ages 6 months to 6 years, typical croup age range. Application to infants <6 months or children >6 years requires cautious interpretation as normal values and severity thresholds may differ. (2) Inter-rater variability—Despite good overall reliability (correlation 0.82-0.88), disagreement occurs particularly in intermediate categories: distinguishing "mild" versus "moderate" retractions or "decreased" versus "markedly decreased" air entry introduces 1-2 point variation. Using multiple assessors or serial assessment by same provider reduces this variability. (3) Timing and situational factors—Scores vary substantially based on child's state: calm in parent's lap versus agitated during examination may differ by 3-5 points. Scoring during acute crying episode from venipuncture or examination produces artificially elevated score not reflecting baseline severity. Optimal scoring occurs with child calm, and reassessment after calming helps determine true severity. (4) Doesn't capture all severity indicators—Factors like SpO2 (oxygen saturation), respiratory rate, heart rate, ability to feed, duration of symptoms, and response to previous treatment provide important context not captured in score. For example, two children both scoring 4 points have different risk profiles if one maintains SpO2 98% while other has SpO2 89%—the latter requires more aggressive management despite identical Westley Score. (5) Plateau effect at extremes—Score maximum of 17 points means variability in "extremely severe" disease isn't captured—a child scoring 14 and another scoring 17 both have critical disease, but degree of difference isn't quantified. Similarly, distinguishing very mild disease (score 0 versus 1) may have limited clinical relevance since both are managed outpatient. (6) Doesn't differentiate croup from alternative diagnoses—High Westley Score indicates severe upper airway obstruction but doesn't distinguish viral croup from bacterial tracheitis, epiglottitis, foreign body, or other causes. Clinical context (fever pattern, prodrome, rapidity of onset, associated symptoms) must guide differential diagnosis. (7) Post-treatment timing interpretation—Improvement after epinephrine is temporary (2-3 hour duration), so scoring during peak effect (30-90 minutes post-treatment) produces falsely reassuring low score that doesn't predict clinical course. Disposition decisions should be based on scores obtained ≥2 hours post-epinephrine when rebound effects have manifested. (8) Parental anxiety and gestalt not incorporated—Experienced clinicians use pattern recognition and gestalt assessment ("this child looks sick") that scores don't capture. Similarly, parental confidence and reliability in home management affects disposition safety independent of objective score. Optimal use integrates Westley Score with comprehensive assessment: Calculate score systematically at presentation documenting all components, interpret score in context of vital signs (especially SpO2), child's age and comorbidities, rapidity of symptom onset, previous croup episodes and their severity, response to initial treatment, time of day (evening/nighttime presentations have fewer follow-up options if deterioration occurs), parental reliability and proximity to medical care, and clinical gestalt. Use score as standardized communication tool and treatment guideline framework while maintaining flexibility for individual circumstances. For example, a child scoring 3 points (mild-moderate, typically observation) with SpO2 88%, age 4 months, and severe parental anxiety warrants admission despite relatively low score, while a child scoring 5 points (moderate-severe, typically observation minimum) who improves to score 1 sustained for 3 hours with reliable parents living 10 minutes from hospital might be safely discharged with clear return precautions. Serial assessment (q2-4 hours for admitted patients) tracks clinical trajectory better than single score—improving trend (7 → 5 → 3 over 6 hours) suggests appropriate treatment and good prognosis, while static/worsening trend (6 → 6 → 7) indicates treatment failure requiring escalation. In summary, Westley Croup Score enhances clinical practice through standardization and objectivity but should complement rather than replace comprehensive clinical assessment and experienced judgment in croup management.